Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read morePress releases
- Real-world effectiveness evidence among GSK data presented at ERS 2019
- GSK receives positive CHMP opinion for intravenous Benlysta in children with lupus aged five years and above
- Nucala is the first biologic approved in the US for six to 11-year-old children with severe eosinophilic asthma
Tweets from GSK
-
GSK @GSK
As @UN focus on Universal Health Coverage today, GSK and @savechildrenuk encourage others to also develop and strengthen partnerships to help provide healthcare for all. Read more: gsk.to/2lZgm0x #HLMUHC #UNGA74 #UHC #HealthForAll
about 47 minutes ago
-
GSK @GSK
#DYK nearly 160,000 new cases of multiple myeloma were diagnosed globally in 2018? That's why we’re dedicated to helping those affected by cancer. Find out more: gsk.to/30g2YIP #BloodCancerAwarenessMonth
about 19 hours ago -
GSK @GSK
Scott Miller, our Global Franchise Scientific Director of Oncology, explains why we’re pursuing scientific developments in blood cancer and researching innovative treatments to address unmet needs for multiple myeloma patients. #BloodCancerAwarenessMonth
about 1 day ago
